Randomized controlled study of the efficacy of pancreatic enzyme replacement therapy with pancrelipase for pancreatic exocrine insufficiency in patients with unresectable pancreatic cancer.
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000009912
- Lead Sponsor
- Chiba Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Gastrointestinal obstruction (2)Severe concurrent disease (3)Pregnant or lactating women (4)Hypersensitivity to porcine or bovine protein, or severe drug hypersensitibity (5)History of gastrointestinal tract surgery (6)Prior chemotherapy or radiotherapy (7)Mental disorder (8)Inadequate physical condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method